Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Drug Candidates
100,0
%
| 92 | 100,0 % | 90 | 100,0 % | -2,10 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Rest of World
87,3
%
| 82 | 89,3 % | 79 | 87,3 % | -4,35 % |
United States
12,7
%
| 10 | 10,7 % | 11 | 12,7 % | +16,66 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Howard Robin
CEO | Chief Executive Officer | 71 | 01/01/07 |
Robert Chess
CHM | Chairman | 66 | 01/12/91 |
Sandra Gardiner
DFI | Director of Finance/CFO | 58 | 17/04/23 |
Chief Tech/Sci/R&D Officer | 49 | 01/07/15 | |
Mary Tagliaferri
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/01/15 |
Vivian Wu
IRC | Investor Relations Contact | - | 01/11/18 |
Robert Bacci
HRO | Human Resources Officer | - | 01/01/01 |
Mark Wilson
LAW | General Counsel | 52 | 01/05/02 |
Jennifer Ruddock
PRN | Corporate Officer/Principal | - | 01/01/04 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
R. Scott Greer
BRD | Director/Board Member | 65 | 01/01/10 |
Roy A. Whitfield
BRD | Director/Board Member | 70 | 01/08/00 |
Robert Chess
CHM | Chairman | 66 | 01/12/91 |
Howard Robin
CEO | Chief Executive Officer | 71 | 01/01/07 |
Jeff Ajer
BRD | Director/Board Member | 61 | 21/09/17 |
Myriam Curet
BRD | Director/Board Member | 67 | 16/12/19 |
Diana Brainard
BRD | Director/Board Member | 53 | 11/11/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 183 617 817 | 182 108 535 ( 99,18 %) | 0 | 99,18 % |
Información de la empresa
Nektar Therapeutics
455 Mission Bay Boulevard South
94158, San Francisco
+415 482 5300
http://www.nektar.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Nektar Therapeutics (India) Pvt Ltd.
Nektar Therapeutics (India) Pvt Ltd. BiotechnologyHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics (India) Pvt Ltd. develops biopharmaceutical products. The private company is based in Hyderabad, India. |
Biotechnology
|
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 661 mil M | |
+27,00 % | 566 mil M | |
-6,76 % | 352 mil M | |
+20,34 % | 332 mil M | |
+3,00 % | 283 mil M | |
+13,09 % | 231 mil M | |
+5,46 % | 200 mil M | |
-9,61 % | 195 mil M | |
-6,26 % | 145 mil M |